{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:52:03Z","timestamp":1784127123767,"version":"3.55.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                  <jats:p>Vancomycin remains one of the most commonly prescribed antibiotics in NICUs despite recommendations to limit its use for known resistant infections. Baseline data revealing substantially higher vancomycin use in our NICU compared to peer institutions informed our quality improvement initiative. Our aim was to reduce the vancomycin prescribing rate in neonates hospitalized in our NICU by 50% within 1 year and sustain for 1 year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>In the 60-bed level IV NICU of an academic referral center, we used a quality improvement framework to develop key drivers and interventions including (1) physician education with benchmarking antibiotic prescribing rates; (2) pharmacy-initiated 48-hour antibiotic time-outs on rounds; (3) development of clinical pathways to standardize empirical antibiotic choices for early-onset sepsis, late-onset sepsis, and necrotizing enterocolitis; coupled with (4) daily prospective audit with feedback from the antimicrobial stewardship program.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>We used statistical process u-charts to show vancomycin use declined from 112 to 38 days of therapy per 1000 patient-days. After education, pharmacy-initiated 48-hour time-outs, and development of clinical pathways, vancomycin use declined by 29%, and by an additional 52% after implementation of prospective audit with feedback. Vancomycin-associated acute kidney injury also declined from 1.4 to 0.1 events per 1000 patient-days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Through a sequential implementation approach of education, standardization of care with clinical pathways, pharmacist-initiated 48-hour time-outs, and prospective audit with feedback, vancomycin days of therapy declined by 66% over a 1-year period and has been sustained for 1 year.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2019-2963","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T12:22:38Z","timestamp":1593606158000},"source":"Crossref","is-referenced-by-count":28,"title":["Reducing Vancomycin Use in a Level IV NICU"],"prefix":"10.1542","volume":"146","author":[{"given":"Rana F.","family":"Hamdy","sequence":"first","affiliation":[{"name":"Infectious Diseases,"},{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopnil","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"Quality and Patient Safety,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeepta K.","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"},{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hahn","sequence":"additional","affiliation":[{"name":"Infectious Diseases,"},{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"},{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor D.","family":"Sadler","sequence":"additional","affiliation":[{"name":"Pharmacy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Hammer","sequence":"additional","affiliation":[{"name":"Pharmacy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Galiote","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"},{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Slomkowski","sequence":"additional","affiliation":[{"name":"Pharmacy Residency Preceptor Program, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Casto","sequence":"additional","affiliation":[{"name":"Neonatology,"},{"name":"Department of Nursing, Children\u2019s National Hospital, Washington, District of Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn P.","family":"Korzuch","sequence":"additional","affiliation":[{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Chase","sequence":"additional","affiliation":[{"name":"Children\u2019s National Research Institute and"},{"name":"Divisions of Biostatistics and Study Methodology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Nzegwu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"},{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Quality and Patient Safety,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Children\u2019s National Research Institute and"},{"name":"Divisions of Biostatistics and Study Methodology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Blake","sequence":"additional","affiliation":[{"name":"Department of Nursing, Children\u2019s National Hospital, Washington, District of Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeho","family":"Chang","sequence":"additional","affiliation":[{"name":"Quality and Patient Safety,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Bost","sequence":"additional","affiliation":[{"name":"Children\u2019s National Research Institute and"},{"name":"Divisions of Biostatistics and Study Methodology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha S.","family":"Payne","sequence":"additional","affiliation":[{"name":"Neonatology,"},{"name":"Emergency Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul K.","family":"Shah","sequence":"additional","affiliation":[{"name":"Quality and Patient Safety,"},{"name":"Otolaryngology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Soghier","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia; and"},{"name":"Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"6","key":"2021121016450552900_B1","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1542\/peds.2005-1707","article-title":"Reported medication use in the neonatal intensive care unit: data from a large national data set","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"2021121016450552900_B2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1542\/peds.2014-3409","article-title":"Neonatal intensive care unit antibiotic use","volume":"135","author":"Schulman","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"2021121016450552900_B3","doi-asserted-by":"crossref","first-page":"e20180115","DOI":"10.1542\/peds.2018-0115","article-title":"Variations in neonatal antibiotic use","volume":"142","author":"Schulman","year":"2018","journal-title":"Pediatrics"},{"issue":"7","key":"2021121016450552900_B4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2105\/AJPH.85.7.957","article-title":"Infant mortality in the United States","volume":"85","author":"Singh","year":"1995","journal-title":"Am J Public Health"},{"issue":"1","key":"2021121016450552900_B5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1542\/peds.2007-3423","article-title":"Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants","volume":"123","author":"Cotten","year":"2009","journal-title":"Pediatrics"},{"key":"2021121016450552900_B6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jpeds.2016.11.002","article-title":"Antibiotic exposure and risk for death or bronchopulmonary dysplasia in very low birth weight infants","volume":"181","author":"Cantey","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"2021121016450552900_B7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3345\/kjp.2013.56.2.68","article-title":"The control of invasive Candida infection in very low birth weight infants by reduction in the use of 3rd generation cephalosporin","volume":"56","author":"Chang","year":"2013","journal-title":"Korean J Pediatr"},{"issue":"10","key":"2021121016450552900_B8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ajic.2013.02.005","article-title":"Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors","volume":"41","author":"Iosifidis","year":"2013","journal-title":"Am J Infect Control"},{"issue":"4","key":"2021121016450552900_B9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/jpids\/piu010","article-title":"Extended-spectrum \u03b2-lactamase-producing and third-generation cephalosporin-resistant enterobacteriaceae in children: trends in the United States, 1999\u20132011","volume":"3","author":"Logan","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"2021121016450552900_B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QCO.0000000000000263","article-title":"Vancomycin toxicity in neonates: a review of the evidence","volume":"29","author":"Lestner","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"2021121016450552900_B11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/pai.12436","article-title":"Prenatal antibiotic use and risk of childhood wheeze\/asthma: a meta-analysis","volume":"26","author":"Zhao","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"2021121016450552900_B12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-3886","article-title":"Antibiotic exposure and IBD development among children: a population-based cohort study","volume":"130","author":"Kronman","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"2021121016450552900_B13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"issue":"9","key":"2021121016450552900_B14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am J Perinatol"},{"issue":"5","key":"2021121016450552900_B15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jped.2016.06.001","article-title":"Empiric therapy with vancomycin in the neonatal intensive care unit: let\u2019s \u201cGet Smart\u201d globally!","volume":"92","author":"S\u00e1nchez","year":"2016","journal-title":"J Pediatr (Rio J)"},{"issue":"12","key":"2021121016450552900_B16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0b013e3181b12484","article-title":"Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance","volume":"28","author":"Patel","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2021121016450552900_B17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/INF.0000000000000542","article-title":"Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study","volume":"34","author":"Cantey","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2021121016450552900_B18","unstructured":"Choosing\u2008Wisely\n          . American Academy of Pediatrics \u2013 Committee on Infectious Diseases and the Pediatric Infectious Diseases Society. 2018. Available at: https:\/\/www.choosingwisely.org\/societies\/american-academy-of-pediatrics-committee-on-infectious-diseases-and-the-pediatric-infectious-diseases-society\/. Accessed March 28, 2019"},{"issue":"10","key":"2021121016450552900_B19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/ice.2019.217","article-title":"Impact of decolonization on methicillin-resistant Staphylococcus aureus transmission and infection in a neonatal intensive care unit","volume":"40","author":"Bozzella","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2021121016450552900_B34","volume-title":"Improving the Reliability of Health Care. IHI Innovation Series White Paper","author":"Nolan","year":"2004"},{"issue":"6","key":"2021121016450552900_B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2021121016450552900_B21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.earlhumdev.2016.12.002","article-title":"Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis: clinical practice guidelines","volume":"105","author":"Gilfillan","year":"2017","journal-title":"Early Hum Dev"},{"issue":"6","key":"2021121016450552900_B22","doi-asserted-by":"crossref","first-page":"e20182896","DOI":"10.1542\/peds.2018-2896","article-title":"Management of neonates born at \u226434 6\/7 weeks\u2019 gestation with suspected or proven early-onset bacterial sepsis","volume":"142","author":"Puopolo","year":"2018","journal-title":"Pediatrics"},{"key":"2021121016450552900_B23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpeds.2018.05.048","article-title":"Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: a prospective population-based cohort study","volume":"201","author":"Giannoni","year":"2018","journal-title":"J Pediatr"},{"issue":"3","key":"2021121016450552900_B24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.21037\/tp.2019.07.02","article-title":"Practice variations and rates of late onset sepsis and necrotizing enterocolitis in very preterm born infants, a review","volume":"8","author":"Adams","year":"2019","journal-title":"Transl Pediatr"},{"issue":"6","key":"2021121016450552900_B25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/tropej\/fmq110","article-title":"Evidence behind the WHO guidelines: hospital care for children: for young infants with suspected necrotizing enterocolitis (NEC), what is the effectiveness of different parenteral antibiotic regimens in preventing progression and sequelae?","volume":"56","author":"Tickell","year":"2010","journal-title":"J Trop Pediatr"},{"issue":"10","key":"2021121016450552900_B26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00134-014-3391-8","article-title":"Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population","volume":"40","author":"Selewski","year":"2014","journal-title":"Intensive Care Med"},{"key":"2021121016450552900_B27","volume-title":"The Health Care Data Guide: Learning From Data for Improvement","author":"Provost","year":"2011"},{"issue":"6","key":"2021121016450552900_B28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1542\/peds.106.6.1387","article-title":"Fulminant late-onset sepsis in a neonatal intensive care unit, 1988\u20131997, and the impact of avoiding empiric vancomycin therapy","volume":"106","author":"Karlowicz","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"2021121016450552900_B29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2431-5-49","article-title":"Cloxacillin versus vancomycin for presumed late-onset sepsis in the neonatal intensive care unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study","volume":"5","author":"Lawrence","year":"2005","journal-title":"BMC Pediatr"},{"issue":"11","key":"2021121016450552900_B30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajic.2015.06.028","article-title":"Decreasing vancomycin utilization in a neonatal intensive care unit","volume":"43","author":"Holzmann-Pazgal","year":"2015","journal-title":"Am J Infect Control"},{"issue":"4","key":"2021121016450552900_B31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/INF.0b013e3182011d12","article-title":"Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit","volume":"30","author":"Chiu","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"2021121016450552900_B32","doi-asserted-by":"crossref","first-page":"e0202439","DOI":"10.1371\/journal.pone.0202439","article-title":"Vancomycin associated acute kidney injury in pediatric patients","volume":"13","author":"Moffett","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"2021121016450552900_B33","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1136\/archdischild-2015-308459","article-title":"A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates","volume":"101","author":"Constance","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2963\/1081090\/peds_20192963.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2963\/1081090\/peds_20192963.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:11:53Z","timestamp":1639199513000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/146\/2\/e20192963\/36930\/Reducing-Vancomycin-Use-in-a-Level-IV-NICU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-2963","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"article-number":"e20192963"}}